Literature DB >> 33572983

Nasopharyngeal Carriage and Antimicrobial Susceptibility Profile of Staphylococcus aureus among Children under Five Years in Accra.

Nicholas T K D Dayie1, Mary-Magdalene Osei1,2, Japheth A Opintan1, Patience B Tetteh-Quarcoo1, Fleischer C N Kotey1,2, John Ahenkorah3, Kevin Kofi Adutwum-Ofosu3, Beverly Egyir4, Eric S Donkor1.   

Abstract

This cross-sectional study investigated the Staphylococcus aureus (S. aureus) and methicillin-resistant S. aureus (MRSA) nasopharyngeal carriage epidemiology in Accra approximately five years post-pneumococcal conjugate vaccines introduction in the country. Archived nasopharyngeal swabs collected from 410 children aged under five years old were bacteriologically cultured. The resultant S. aureus isolates were subjected to antimicrobial susceptibility testing and screening for carriage of the mecA and LukF-PV (pvl) genes, following standard procedures. The data obtained were analyzed with Statistical Products and Services Solutions (SPSS) using descriptive statistics and Chi square tests of associations. The isolated bacteria decreased across coagulase-negative Staphylococci (47.3%, n = 194), S. aureus (23.2%, n = 95), Diphtheroids (5.4%, n = 22), Micrococcus species (3.7%, n = 15), Klebsiella pneumoniae (3.2%, n = 13), Moraxella species and Citrobacter species (1.5% each, n = 6), Escherichia coli, Enterobacter species, and Pseudomonas species (0.9% each, n = 2). The MRSA carriage prevalence was 0.49% (n = 2). Individuals aged 37-48 months recorded the highest proportion of S. aureus carriage (32.6%, 31/95). Resistance of S. aureus to the antibiotics tested were penicillin G (97.9%, n = 93), amoxiclav (20%, n = 19), tetracycline (18.9%, n = 18), erythromycin (5.3%, n = 5), ciprofloxacin (2.1%, n = 2), gentamicin (1.1%, n = 1), cotrimoxazole, clindamycin, linezolid, and teicoplanin (0% each). No inducible clindamycin resistance was observed for the erythromycin-resistant isolates. Three (3.2%) of the isolates were multidrug resistant, of which 66.7% (2/3) were MRSA. The pvl gene was associated with 59.14% (55/93) of the methicillin-sensitive S. aureus (MSSA) isolates, but was not detected among any of the MRSA isolates.

Entities:  

Keywords:  MRSA; Staphylococcus aureus; children; nasopharyngeal carriage

Year:  2021        PMID: 33572983      PMCID: PMC7912391          DOI: 10.3390/pathogens10020136

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  72 in total

1.  The bacteriology of the nasopharynx in childhood.

Authors:  A Leiberman; R Dagan; E Leibovitz; P Yagupsky; D M Fliss
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1999-10-05       Impact factor: 1.675

2.  Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children.

Authors:  D Bogaert; A van Belkum; M Sluijter; A Luijendijk; R de Groot; H C Rümke; H A Verbrugh; P W M Hermans
Journal:  Lancet       Date:  2004-06-05       Impact factor: 79.321

3.  High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center.

Authors:  Linda L Han; Linda K McDougal; Rachel J Gorwitz; Kenneth H Mayer; Jean B Patel; Janet M Sennott; John L Fontana
Journal:  J Clin Microbiol       Date:  2007-02-07       Impact factor: 5.948

4.  Characterization of Staphylococcus aureus from Human Immunodeficiency Virus (HIV) patients in Accra, Ghana.

Authors:  Beverly Egyir; Akwasi Ampofo Oteng; Enid Owusu; Mercy Jemimah Newman; Kennedy Kwasi Addo; Anders Rhod-Larsen
Journal:  J Infect Dev Ctries       Date:  2016-05-31       Impact factor: 0.968

5.  Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule.

Authors:  Selma P Wiertsema; Lea-Ann S Kirkham; Karli J Corscadden; Eva N Mowe; Jacinta M Bowman; Peter Jacoby; Richard Francis; Shyan Vijayasekaran; Harvey L Coates; Thomas V Riley; Peter Richmond
Journal:  Vaccine       Date:  2011-05-27       Impact factor: 3.641

6.  Costs of routine immunization and the introduction of new and underutilized vaccines in Ghana.

Authors:  Jean-Bernard Le Gargasson; Frank K Nyonator; Moses Adibo; Bradford D Gessner; Anaïs Colombini
Journal:  Vaccine       Date:  2015-05-07       Impact factor: 3.641

7.  spa typing directly from a mecA, spa and pvl multiplex PCR assay-a cost-effective improvement for methicillin-resistant Staphylococcus aureus surveillance.

Authors:  A R Larsen; M Stegger; M Sørum
Journal:  Clin Microbiol Infect       Date:  2008-04-03       Impact factor: 8.067

8.  The impact of childhood vaccines on bacterial carriage in the nasopharynx: a longitudinal study.

Authors:  Christian Bottomley; Abdoulie Bojang; Peter G Smith; Ousainou Darboe; Martin Antonio; Ebenezer Foster-Nyarko; Beate Kampmann; Brian Greenwood; Umberto D'Alessandro; Anna Roca
Journal:  Emerg Themes Epidemiol       Date:  2015-01-16

9.  Aetiology of Acute Lower Respiratory Infections among Children Under Five Years in Accra, Ghana.

Authors:  Theophilus K Adiku; Richard H Asmah; Onike Rodrigues; Bamenla Goka; Evangeline Obodai; Andrew A Adjei; Eric S Donkor; George Armah
Journal:  Pathogens       Date:  2015-01-26

10.  Nasal Carriage of Staphylococcus aureus among Children in the Ashanti Region of Ghana.

Authors:  Daniel Eibach; Michael Nagel; Benedikt Hogan; Clinton Azuure; Ralf Krumkamp; Denise Dekker; Mike Gajdiss; Melanie Brunke; Nimako Sarpong; Ellis Owusu-Dabo; Jürgen May
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

View more
  1 in total

1.  Alarming Levels of Multidrug Resistance in Aerobic Gram-Negative Bacilli Isolated from the Nasopharynx of Healthy Under-Five Children in Accra, Ghana.

Authors:  Mary-Magdalene Osei; Nicholas T K D Dayie; Godfred S K Azaglo; Elizabeth Y Tettey; Edmund T Nartey; Ama P Fenny; Marcel Manzi; Ajay M V Kumar; Appiah-Korang Labi; Japheth A Opintan; Eric Sampane-Donkor
Journal:  Int J Environ Res Public Health       Date:  2022-09-01       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.